| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections0 v7 n' k0 D/ P) ]" _. v- k1 M
Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes3 @! U9 {( P5 m2 K5 l
Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
! \+ o0 q) L& y. N7 u Press Release |
| 20. & _& e! G) ^9 J% n+ Y
3 A ^0 h7 j: q | | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers3 W- U8 |5 |( c2 Q7 Z' ^/ @
Press Release |
| 19. | Kerydin- ?* x6 @( u& I% Y" ~ @
- D) A' c* u, o' @
| tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails 7 j" R) U5 C0 k5 w! u
(No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) ! J! m) T+ A* @+ s
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections- ~# w( Z6 Z$ Y1 L& U( t
Press Release |
| 16. | Jublia
! P) L9 ^0 S' K/ o: B" J( z- S # S8 O/ }' ]/ A, G7 W5 o
| efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)& `& |, h8 i) Q8 {8 N; U& H+ J9 W
No Press Release |
| 15. | Dalvance, Y4 v* k! [+ J) o; ]
# v1 O7 j* J" U4 `/ C/ c$ X
| dalbavancin | 5/23/2014 | To treat adults with skin infections. y/ b: F( W2 t9 ?% e8 i4 P2 |
Press Release |
| 14. | Entyvio
: \8 x3 ^, {4 B b7 n6 z/ H' b5 n 2 C+ X. n: G4 q& ?/ ~
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease, j" W) d1 f4 C% U3 G! Z, G3 L
Press Release |
| 13. | Zontivity
4 Z" g, Y }+ n( u
! j- h( p5 n4 b/ m1 p& F | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients
% I9 Q% m: \* p" z# a Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)
8 L: m W0 k6 ]# B8 m Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)1 V5 `2 c! {: ?; P% s: }/ e
Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma
% v: x! V1 ]5 N/ s Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
3 j2 `! M. V* N1 T+ s A1 V1 ~ Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA); U7 M9 ~# W& d/ W; x+ |/ A: [ h* g* P
Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis
! m! w/ I) f8 \+ B; W8 i2 a9 s Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency$ B; ]+ C8 C9 P9 v: T! [
Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)$ N: Y- r) o9 \$ E$ y: g& x
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)1 e# b; X, z1 s v& `
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
% r; ^/ f' u$ y K" _) a Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对